BillionToOne, Inc.
NASDAQBillionToOne enters September navigating its sharpest monthly correction since listing, with analysts recalibrating targets and short sellers quietly adding exposure into the weakness. The month-to-date story is stark. The stock has fallen 33% over the past month to $92.32, recovering just 1.8% on Tuesday but still down 7.7% on the week. The catalyst was an August 5 earnings print…
BLLN short interest surges 33% in one week to 2.4M shares as stock rallies 12%, signaling intensifying bearish conviction despite recent gains.
BillionToOne enters September navigating its sharpest monthly correction since listing, with analysts recalibrating targets and short sellers quietly adding exposure into the weakness. The month-to-date story is stark.…
BillionToOne enters the post-earnings stretch with a striking divergence: short sellers have been covering rapidly, but options traders have turned the most defensively positioned they have been in months. The most…
Snapshot as of 20 Sept 2026
BillionToOne is sending mixed signals. The cost to borrow has crashed 79% in a week. Yet short positions are rising again — and options traders are the most bearish they've been in months. CTB peaked above 210% in…
BillionToOne enters the week after a sharp 11% single-day rally on May 6, but short sellers are not backing down — making this stock one of the most pressured borrowing situations in healthcare right now. The lending…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BLLN — free to start on ORTEX.
Sign up for free →Open BLLN on ORTEX